Douglas C. Watson

Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1

Douglas C. Watson, John Farley · The Pediatric Infectious Disease Journal · 1999 · 203 citations

Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A

Ali Fattom, Rachel Schneerson, Douglas C. Watson et al. · Infection and Immunity · 1993 · 134 citations · Full text

Immunology, Adult Volunteers, Immunotherapy +17

Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid

Chiayung Chu, B K Liu, Douglas C. Watson et al. · Infection and Immunity · 1991 · 107 citations · Full text

Vaccination, Type 1, Mucosal Vaccination +14

Continued Production of Drug-Sensitive Human Immunodeficiency Virus Type 1 in Children on Combination Antiretroviral Therapy Who Have Undetectable Viral Loads

Deborah Persaud, George K. Siberry, Aima A. Ahonkhai et al. · Journal of Virology · 2003 · 103 citations · Full text

Combination Antiretroviral Therapy, Immunology, Antiviral Drug +17

Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine

Douglas C. Watson, John B. Robbins, Shousun C. Szu · Infection and Immunity · 1992 · 100 citations · Full text

Vaccination, Vaccine Development, Salmonella Infections +14